Reclast
- Product NDC
- 0078-0435
- 11-digit product format
- 000780435
- Labeler code
- 0078
- Product ID
- 0078-0435_ae5a6cfc-93e8-4095-be3d-b4db71b57545
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- zoledronic acid
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA021817
- Marketing category
- NDA
- Marketing start
- 2007-04-01
- Marketing end
- 0000-00-00
- Substance
- ZOLEDRONIC ACID
- Active strength
- 5 mg/100mL
- Pharmacologic classes
- Bisphosphonate [EPC], Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0078-0435 | RECLAST (ZOLEDRONIC ACID) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 22 | Legacy NDC | 20220709_3c79ff9c-a6f4-405d-b19c-7e473a61dedc.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0078-0435-61 | 00078043561 | 100 mL in 1 BOTTLE (0078-0435-61) | 100 ml | 2007-04-01 | 0000-00-00 | No | No | Current |